These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2926604)

  • 41. A pathologist-designed imaging system for anatomic pathology signout, teaching, and research.
    Schubert E; Gross W; Siderits RH; Deckenbaugh L; He F; Becich MJ
    Semin Diagn Pathol; 1994 Nov; 11(4):263-73. PubMed ID: 7878302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Particulate matter in small volume parenterals: evaluation of some technological and analytical aspects.
    Cirannni Signoretti E; Montanari I; Neri G; De Sena C; Alimonti S
    Boll Chim Farm; 1989 Feb; 128(2):65-70. PubMed ID: 2775519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Traditional and innovative diagnostic tools: when and why they should be applied].
    Cancrini G; Iori A
    Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cluster computing for digital microscopy.
    Carrington WA; Lisin D
    Microsc Res Tech; 2004 Jun; 64(2):204-13. PubMed ID: 15352092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3D parallel coordinate systems--a new data visualization method in the context of microscopy-based multicolor tissue cytometry.
    Streit M; Ecker RC; Osterreicher K; Steiner GE; Bischof H; Bangert C; Kopp T; Rogojanu R
    Cytometry A; 2006 Jul; 69(7):601-11. PubMed ID: 16680710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The evaluation of sizing accuracy of particle counters for parenteral drugs.
    Fujishita O; Sendo T; Hisazumi A; Otsubo K; Aoyama T; Oishi R
    PDA J Pharm Sci Technol; 1995; 49(6):267-71. PubMed ID: 8581457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a simple method for visual detection of microprecipitates in blends of parenteral drug solutions using a focused (tyndall) light beam.
    Veggeland T; Brandl M
    Int J Pharm Compd; 2010; 14(1):78-81. PubMed ID: 23965374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of acceptance criteria for particulate limits for small-volume parenteral products.
    Tsuji K; Lewis AR
    J Pharm Sci; 1978 Jan; 67(1):50-5. PubMed ID: 619115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring of subvisible particles in therapeutic proteins.
    Singh SK; Toler MR
    Methods Mol Biol; 2012; 899():379-401. PubMed ID: 22735966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of factors influencing ampoule secondary particulate contamination. A strategy for its reduction in small volume parenterals.
    Bernuzzi M; Raggi P; Montanari L
    Boll Chim Farm; 1991 Sep; 130(8):323-8. PubMed ID: 1801862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new coincidence model for single particle counters, Part II: Advances and applications.
    Knapp JZ; Lieberman A; Abramson LR
    PDA J Pharm Sci Technol; 1994; 48(5):255-92. PubMed ID: 8000900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Application of automated image analysis system Allegro-MC for morphometric research].
    Chertok VM; Afanas'ev AA; Kotsiuba AE
    Morfologiia; 2003; 124(4):88-93. PubMed ID: 14628565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Critical evaluation and guidance for using the Coulter method for counting subvisible particles in protein solutions.
    Barnard JG; Rhyner MN; Carpenter JF
    J Pharm Sci; 2012 Jan; 101(1):140-53. PubMed ID: 22109687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measuring Subvisible Particles in Protein Formulations Using a Modified Light Obscuration Sensor with Improved Detection Capabilities.
    Ríos Quiroz A; Québatte G; Stump F; Finkler C; Huwyler J; Schmidt R; Mahler HC; Koulov AV; Adler M
    Anal Chem; 2015 Jun; 87(12):6119-24. PubMed ID: 26001042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compendial Methods: Suitability Verification, Challenges and Recommendations for Proteins.
    Chung WL; Yin J; Messick S; Saggu M; Tschudi K; Woys A; Rahimi R; Azarias M; Kong C; Kabakoff B
    PDA J Pharm Sci Technol; 2020; 74(5):581-591. PubMed ID: 32295862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [3d symposium. Morphometry in research and clinical practice with special reference to automated microscopic image analysis].
    Gegenbaurs Morphol Jahrb; 1989; 135(1):1-125. PubMed ID: 2737405
    [No Abstract]   [Full Text] [Related]  

  • 57. Particle image identification and correlation analysis in microscopic holographic particle image velocimetry.
    Wormald SA; Coupland J
    Appl Opt; 2009 Nov; 48(33):6400-7. PubMed ID: 19935958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variable Threshold Method for Determining the Boundaries of Imaged Subvisible Particles.
    Cavicchi RE; Collett C; Telikepalli S; Hu Z; Carrier M; Ripple DC
    J Pharm Sci; 2017 Jun; 106(6):1499-1507. PubMed ID: 28209364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microscopic image analysis techniques for the morphological characterization of pharmaceutical particles: Influence of process variables.
    Almeida-Prieto S; Blanco-Méndez J; Otero-Espinar FJ
    J Pharm Sci; 2006 Feb; 95(2):348-57. PubMed ID: 16372305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative Evaluation of Insoluble Particulate Matters in Therapeutic Protein Injections Using Light Obscuration and Flow Imaging Methods.
    Shibata H; Harazono A; Kiyoshi M; Ishii-Watabe A
    J Pharm Sci; 2022 Mar; 111(3):648-654. PubMed ID: 34619153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.